Anna Alassaad

809 total citations
6 papers, 629 citations indexed

About

Anna Alassaad is a scholar working on Geriatrics and Gerontology, Pediatrics, Perinatology and Child Health and Family Practice. According to data from OpenAlex, Anna Alassaad has authored 6 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Geriatrics and Gerontology, 3 papers in Pediatrics, Perinatology and Child Health and 2 papers in Family Practice. Recurrent topics in Anna Alassaad's work include Pharmaceutical Practices and Patient Outcomes (6 papers), Pharmaceutical studies and practices (3 papers) and Medication Adherence and Compliance (2 papers). Anna Alassaad is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (6 papers), Pharmaceutical studies and practices (3 papers) and Medication Adherence and Compliance (2 papers). Anna Alassaad collaborates with scholars based in Sweden. Anna Alassaad's co-authors include Margareta Hammarlund‐Udenaes, Ulrika Gillespie, Håkan Melhus, Dan Henrohn, Claes Mörlin, Hans Garmo, Henrik Toss, Åsa Kettis-Lindblad, Maria Bertilsson and Johan Sundström and has published in prestigious journals such as PLoS ONE, BMJ Open and Journal of Evaluation in Clinical Practice.

In The Last Decade

Anna Alassaad

6 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Alassaad Sweden 6 570 201 198 144 135 6 629
Ulrika Gillespie Sweden 13 780 1.4× 256 1.3× 264 1.3× 186 1.3× 172 1.3× 30 873
Tamasine Grimes Ireland 13 508 0.9× 267 1.3× 117 0.6× 137 1.0× 88 0.7× 39 666
Michael Cotugno United States 7 585 1.0× 276 1.4× 93 0.5× 192 1.3× 130 1.0× 19 792
Mark S. Horng United States 5 562 1.0× 245 1.2× 99 0.5× 194 1.3× 214 1.6× 7 826
Olavo Fernandes Canada 11 524 0.9× 279 1.4× 81 0.4× 130 0.9× 86 0.6× 29 737
Brad J. McClimon United States 5 727 1.3× 368 1.8× 148 0.7× 158 1.1× 81 0.6× 5 879
Charles D. Sintek United States 15 444 0.8× 86 0.4× 213 1.1× 172 1.2× 107 0.8× 22 699
Tommy Westerlund Sweden 16 635 1.1× 139 0.7× 170 0.9× 198 1.4× 63 0.5× 26 881
Catherine L. Liang United States 8 476 0.8× 337 1.7× 85 0.4× 116 0.8× 78 0.6× 8 791
Stephanie Labonville United States 12 687 1.2× 438 2.2× 104 0.5× 210 1.5× 150 1.1× 13 894

Countries citing papers authored by Anna Alassaad

Since Specialization
Citations

This map shows the geographic impact of Anna Alassaad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Alassaad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Alassaad more than expected).

Fields of papers citing papers by Anna Alassaad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Alassaad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Alassaad. The network helps show where Anna Alassaad may publish in the future.

Co-authorship network of co-authors of Anna Alassaad

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Alassaad. A scholar is included among the top collaborators of Anna Alassaad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Alassaad. Anna Alassaad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Alassaad, Anna, Håkan Melhus, Margareta Hammarlund‐Udenaes, et al.. (2015). A tool for prediction of risk of rehospitalisation and mortality in the hospitalised elderly: secondary analysis of clinical trial data. BMJ Open. 5(2). e007259–e007259. 37 indexed citations
2.
Alassaad, Anna, Maria Bertilsson, Ulrika Gillespie, et al.. (2014). The Effects of Pharmacist Intervention on Emergency Department Visits in Patients 80 Years and Older: Subgroup Analyses by Number of Prescribed Drugs and Appropriate Prescribing. PLoS ONE. 9(11). e111797–e111797. 23 indexed citations
4.
Alassaad, Anna, Ulrika Gillespie, Maria Bertilsson, Håkan Melhus, & Margareta Hammarlund‐Udenaes. (2011). Prescription and transcription errors in multidose‐dispensed medications on discharge from hospital: an observational and interventional study. Journal of Evaluation in Clinical Practice. 19(1). 185–191. 13 indexed citations
5.
Gillespie, Ulrika, Anna Alassaad, Dan Henrohn, et al.. (2009). A Comprehensive Pharmacist Intervention to Reduce Morbidity in Patients 80 Years or Older. Archives of Internal Medicine. 169(9). 894–894. 9 indexed citations
6.
Gillespie, Ulrika, Anna Alassaad, Dan Henrohn, et al.. (2009). A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial.. PubMed. 169(9). 894–900. 451 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026